Teva Pharmaceutical Industries Limited (
) will begin trading ex-dividend on August 16, 2013. A cash
dividend payment of $0.322 per share is scheduled to be paid on
September 03, 2013. Shareholders who purchased TEVA stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This represents an 0.63% increase over the prior quarter. At the
current stock price of $39.85, the dividend yield is 3.23%.
The previous trading day's last sale of TEVA was $39.85,
representing a -6.96% decrease from the 52 week high of $42.83 and
a 8.79% increase over the 52 week low of $36.63.
TEVA is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). TEVA's current earnings per share, an indicator of a company's
profitability, is $.49. Zacks Investment Research reports TEVA's
forecasted earnings growth in 2013 as -6.61%, compared to an
industry average of -5.8%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to TEVA through an Exchange
Traded Fund [ETF]?
The following ETF(s) have TEVA as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- iShares MSCI Israel Capped Investable Market Index Fund (
- iShares MSCI ACWI ex US Healthcare ETF (
The top-performing ETF of this group is AXHE with an increase of
9.61% over the last 100 days. PPH has the highest percent weighting
of TEVA at 4.55%.